33652000-5categoryAntineoplastic and immunomodulating agents tenders
5 open antineoplastic and immunomodulating agents tenders right now within General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. CPV 33652000-5 classifies antineoplastic and immunomodulating agents across European public procurement.
Antineoplastic and immunomodulating agents tenders closing soon
Sorted by deadlineDZP.242.405.2026 - Dostawa produktów leczniczych – leki hematoonkologiczne (cytotoksyczne)
UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIUTED Member StatesSource
Deadline2d leftImunosupresiva - inhibitory TNF alfa II.
Institut klinické a experimentální medicínyTED Member StatesSource
Deadline3d leftDostawa leku Adagrasibu
Wielkopolskie Centrum Pulmonologii i Torakochirurgii im. eugenii i Janusza ZeylandówTED Member StatesSource
Tenders due6d leftAdquisición del medicamento Infliximab
Hospital Universitario Infanta LeonorPLACSP (Spain)Source
€676kTenders due6d leftAdquisición del medicamento Infliximab
Hospital Universitario Infanta LeonorTED Member StatesSource
€676kDeadline6d leftDodávky léků – Léčivá látka lorlatinib – ATC L01ED05
Fakultní Thomayerova nemocniceTED Member StatesSource
Deadline6d leftLP s obsahem ramucirumabu 2026 - sdružený nákup
Fakultní nemocnice OlomoucTED Member StatesSource
Deadline6d leftDodávky léků – Léčivá látka enkorafenib – ATC L01EC03
Fakultní Thomayerova nemocniceTED Member StatesSource
Deadline6d leftLP s obsahem ofatumumabu 2026 - sdružený nákup
Fakultní nemocnice OlomoucTED Member StatesSource
Deadline27 Oct 2026DOSTAWA LEKÓW ONKOLOGICZNYCH DLA WOJEWÓDZKIEGO SZPITALA SPECJALISTYCZNEGO IM. NAJŚWIĘTSZEJ MARYI PANNY W CZĘSTOCHOWIE
Wojewódzki Szpital Specjalistyczny Im. Najświętszej Maryi PannyTED Member StatesSource
Deadline27 Oct 2026Dodávky léků – Léčivá látka rozanolixizumab – ATC L04AL02
Fakultní Thomayerova nemocniceTED Member StatesSource
Deadline27 Oct 2026Dodávky léků – Léčivá látka efgartigimod alfa – ATC L04AL01
Fakultní Thomayerova nemocniceTED Member StatesSource
Deadline27 Oct 2026
By the numbers
Open now
5
Notices all-time
1,757
Typical value (median)
€617k
€308k – €967k
Last published
29 May 2026
Top sources
Buyer and value figures for this level are aggregated from sub-codes and may be approximate.
Frequently asked questions
- What is CPV code 33652000-5?
- CPV 33652000-5 (Antineoplastic and immunomodulating agents) is a Common Procurement Vocabulary code used across European public procurement to classify antineoplastic and immunomodulating agents contracts. Buyers tag notices with this code so suppliers can find relevant tenders.
- How many antineoplastic and immunomodulating agents tenders are open right now?
- Tender Radar is currently tracking 5 open antineoplastic and immunomodulating agents (CPV 33652000-5) tenders, out of 1,757 notices published all-time.
- What is the typical value of a antineoplastic and immunomodulating agents contract?
- The median estimated value of a antineoplastic and immunomodulating agents (CPV 33652000-5) contract is around €616,776. Values vary widely by buyer and scope.
- Where are antineoplastic and immunomodulating agents tenders published?
- Antineoplastic and immunomodulating agents (CPV 33652000-5) notices are aggregated from sources including Portal BASE, TED Member States, PLACSP (Spain), alongside other European procurement portals tracked by Tender Radar.
Track antineoplastic and immunomodulating agents tenders automatically
Tender Radar monitors CPV 33652000-5 tenders across European procurement portals and matches them to your company profile. Get relevant antineoplastic and immunomodulating agents opportunities in a daily or weekly digest.